ERAS Archived Articles
Erasca (ERAS): Pioneering the Fight Against RAS/MAPK-Driven Cancers
Published on November 05, 2024
Erasca, Inc. (NASDAQ:ERAS): Unlocking the Potential of RAS/MAPK Pathway Inhibition
Published on September 24, 2024
